DataArt's engineering capabilities with xCures' oncology expertise created a Natural Language Processing tool. This collaboration tackles the difficult task of ingesting a patient's health records, parsing free-text cancer notes, in order to help patients navigate their options for oncology treatments.
This Conversation Specifically Addresses:
The unique challenges facing xCuresHow DataArt and xCures began their collaborationThe ongoing conversations required to create something novel and get the finished product to the end user: the patient Plus how this technology could positively impact clinical trial matching
About the Speakers:
Jamie McCulloch is Vice President of Client Solutions at DataArt. DataArt is a global software engineering firm with over 25 years of experience, teams of highly-trained engineers around the world, deep industry sector knowledge, and ongoing technology research, to help clients create custom software that improves their operations and opens new markets.
Mark Shapiro, Chief Operating Officer of xCures, is a management consultant and drug development expert with over 20 years of experience leading growth, innovation, and business transformation in clinical research and development. xCures is an AI-supported platform predicting top treatment options for cancer patients and creating RWE suitable for FDA submissions.
Lia Parsenadze is a Data Scientist at DataArt, with professional interests revolving around AI/ML/DL, particularly in medical applications.
For more information about cancer research, click here.
Podden och tillhörande omslagsbild på den här sidan tillhör Pharma Talk Radio. Innehållet i podden är skapat av Pharma Talk Radio och inte av, eller tillsammans med, Poddtoppen.
